Status:

UNKNOWN

Helping Improve Pediatric Patient Outcomes

Lead Sponsor:

Kaiser Permanente

Collaborating Sponsors:

Seattle Children's Hospital

Conditions:

Pediatric Cancer, Animal-Assisted Activities

Eligibility:

All Genders

5-17 years

Phase:

NA

Brief Summary

This study involves two distinct activities: The first is a randomized controlled trial (RCT) to assess the efficacy and safety of therapy dog visits for children with cancer. This activity has the f...

Detailed Description

This study tests whether therapy dog visits reduce distress, lower treatment-related anxiety, increase happiness, and improve satisfaction with hospital care, and whether these visits transmit pathoge...

Eligibility Criteria

Inclusion

  • English-speaking patients aged 5-17 years who have been admitted to the Seattle Children's Hospital Cancer Care Unit and who are on the oncology service irrespective of specific oncologic diagnosis, sex, race, and ethnicity.

Exclusion

  • Are allergic to dogs or have a sensitivity to dogs; Are afraid of dogs; Are on the bone marrow transplant service; Have isolation precautions in place per Infection Prevention policies (e.g. viral respiratory precautions, contact precautions, etc.); Skin on hands not intact (e.g. moderate to severe eczema involving the hands or other generalized skin breakdown); Have no English-speaking parent/legal guardian; Have no parent/legal guardian able to provide written consent; For observational study, unwilling or unable to pet the dog with both hands.

Key Trial Info

Start Date :

March 19 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2022

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT03471221

Start Date

March 19 2018

End Date

April 30 2022

Last Update

March 31 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Kaiser Permanente Washington Health Research Institute

Seattle, Washington, United States, 98101

2

Kaiser Permanente Washington Health Research Institute

Seattle, Washington, United States, 98126

Helping Improve Pediatric Patient Outcomes | DecenTrialz